A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis

NCT05579925 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

BIOLOGICAL: CM310

Sponsor

Keymed Biosciences Co.Ltd